ConductScience.org, home

Paper15257707

The recurrent translocation t(14;20)(q32;q12) in multiple myeloma results in aberrant expression of MAFB: a molecular and genetic analysis of the chromosomal breakpoint.

Boersma-Vreugdenhil GR and 8 others. Br J Haematol, 2004. Cited by 43 papers, by iCite.

Cite this record

ConductScience Library. The recurrent translocation t(14;20)(q32;q12) in multiple myeloma results in aberrant expression of MAFB: a molecular and genetic analysis of the chromosomal breakpoint. Papers, record 15257707. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/15257707

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
The recurrent translocation t(14;20)(q32;q12) in multiple myeloma results in aberrant expression of MAFB: a molecular and genetic analysis of the chromosomal breakpoint.
PubMed
Journal
Br J Haematol
PubMed
Year
2004
PubMed
Publication types
Journal Article, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
43
iCite
Relative citation ratio, by iCite
0.73
iCite
Revised in PubMed
2006-11-15
PubMed

Authors9

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Boersma-Vreugdenhil GRGienke R
2Kuipers JJeroen
3Van Stralen EEsther
4Peeters TTon
5Michaux LLucienne
6Hagemeijer AAnne
7Pearson PLPeter L
8Clevers HCHans C
9Bast BJBert J E G

Source PubMed

Download CSV of authors

Topics18

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Avian ProteinsMajor topic
Chromosomes, Human, Pair 14Major topic
Chromosomes, Human, Pair 20Major topic
DNA-Binding ProteinsMajor topic
Multiple MyelomaMajor topic
Oncogene ProteinsMajor topic
Transcription FactorsMajor topic
Translocation, GeneticMajor topic
Aged
Blotting, Northern
Cell Line, Tumor
Female
Gene Expression
Humans
In Situ Hybridization, Fluorescence
MafB Transcription Factor
Polymerase Chain Reaction
Sequence Analysis, DNA

Source PubMed

Download CSV of topics

Cited by23

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 43 citations.

PMIDTitleJournalYearIn PapersSource
40796955Activated MAFB in ovarian cancer promotes cytoskeletal remodeling and immune microenvironment suppression by interfering with m6A modifications through WTAP competition.Oncogene2025https://conductscience.org/library/papers/40796955PubMed
40506426MAFB: a key regulator of myeloid commitment involved in hematological diseases.Cell Death Discov2025https://conductscience.org/library/papers/40506426PubMed
39160255Comprehensive molecular profiling of multiple myeloma identifies refined copy number and expression subtypes.Nat Genet2024https://conductscience.org/library/papers/39160255PubMed
37692492Cellular senescence-driven transcriptional reprogramming of the MAFB/NOTCH3 axis activates the PI3K/AKT pathway and promotes osteosarcoma progression.Genes Dis2024https://conductscience.org/library/papers/37692492PubMed
36775962Hypoxia-induced oxidative stress promotes therapy resistance via upregulation of heme oxygenase-1 in multiple myeloma.Cancer Med2023https://conductscience.org/library/papers/36775962PubMed
36750911The role and regulation of Maf proteins in cancer.Biomark Res2023https://conductscience.org/library/papers/36750911PubMed
36071980A personalized molecular approach in multiple myeloma: the possible use of RAF/RAS/MEK/ERK and BCL-2 inhibitors.Explor Target Antitumor Ther2022https://conductscience.org/library/papers/36071980PubMed
34885058Genome Instability in Multiple Myeloma: Facts and Factors.Cancers (Basel)2021https://conductscience.org/library/papers/34885058PubMed
34215221Differential gene expression identifies a transcriptional regulatory network involving ER-alpha and PITX1 in invasive epithelial ovarian cancer.BMC Cancer2021https://conductscience.org/library/papers/34215221PubMed
33357482Bortezomib, lenalidomide, and dexamethasone with or without elotuzumab in patients with untreated, high-risk multiple myeloma (SWOG-1211): primary analysis of a randomised, phase 2 trial.Lancet Haematol2021https://conductscience.org/library/papers/33357482PubMed
32050631Multiple Myeloma: Available Therapies and Causes of Drug Resistance.Cancers (Basel)2020https://conductscience.org/library/papers/32050631PubMed
31582643Role of MafB in macrophages.Exp Anim2020https://conductscience.org/library/papers/31582643PubMed
29980194MAFb protein confers intrinsic resistance to proteasome inhibitors in multiple myeloma.BMC Cancer2018https://conductscience.org/library/papers/29980194PubMed
29686421The multiple myelomas - current concepts in cytogenetic classification and therapy.Nat Rev Clin Oncol2018https://conductscience.org/library/papers/29686421PubMed
27829226SUMOylated MAFB promotes colorectal cancer tumorigenesis.Oncotarget2016https://conductscience.org/library/papers/27829226PubMed
26883334Risk Stratification in Multiple Myeloma.Curr Hematol Malig Rep2016https://conductscience.org/library/papers/26883334PubMed
24638926In multiple myeloma, 14q32 translocations are nonrandom chromosomal fusions driving high expression levels of the respective partner genes.Genes Chromosomes Cancer2014https://conductscience.org/library/papers/24638926PubMed
24442204GSK3-mediated MAF phosphorylation in multiple myeloma as a potential therapeutic target.Blood Cancer J2014https://conductscience.org/library/papers/24442204PubMed
22961061The t(4;14) translocation and FGFR3 overexpression in multiple myeloma: prognostic implications and current clinical strategies.Blood Cancer J2012https://conductscience.org/library/papers/22961061PubMed
18830254MafB oncoprotein detected by immunohistochemistry as a highly sensitive and specific marker for the prognostic unfavorable t(14;20) (q32;q12) in multiple myeloma patients.Leukemia2009https://conductscience.org/library/papers/18830254PubMed

See all 23 cited byDownload CSV of cited by

Genes2

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
IGHD3495PubTator's text mininghttps://conductscience.org/library/genes/3495NCBI Gene
MAFB9935PubTator's text mininghttps://conductscience.org/library/genes/9935NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/15257707

GET https://conductscience.org/api/papers/v1/15257707/cited_by?page=2